Abstract -A stereoselective synthesis of D-1-deoxynojirimycin (1), D-1-deoxymannojirimycin (2), and D-1-deoxyallonojirimycin (3) was achieved via the regioselective and diastereoselective amination of anti-1,2-dibenzyl ether using chlorosulfonyl isocyanate (CSI), ring-closing metathesis, diastereoselective dihydroxylation, and the regioselective stereochemical inversion of the resulting diol.
INTRODUCTION
Polyhydroxylated piperidine alkaloids and their synthetic analogs have attracted a great deal of attention because they selectively inhibit glycosidases and glycotransferases. 1 In particular, D-1-deoxyazasugars, such as, D-1-deoxynojirimycin (1, DNJ), (3, , 4 have been reported to inhibit various glycosidases in a reversible or competitive manner due to their structural resemblances to the sugar moieties of natural substrates. 5 For example, D-1-deoxynojirimycin (1) , isolated from Morus alba in 1976, 6 significantly inhibits all mammalian α-glycosidase types. 7 Also, D-1-deoxymannojirimycin (2) , isolated from Lonchocarpus sericeus in 1979, 8 potently inhibits α-D-mannosidase, α-D-glucosidase and α-L-fucosidase. In connection with our previous project, on the chlorosulfonyl isocyanate (CSI)-mediated stereoselective amination of various allylic ethers 14 and the application of this method to the enantioselective synthesis of polyhydroxylated alkaloids, 15 we considered that the stereoselective total synthesis of D-1-deoxynojirimycin (1) and of its stereoisomers 2 and 3 would be possible via the stereoselective dihydroxylation of the common intermediate 6 produced during the synthesis of (2S,3S)-3-hydroxypipecolic acid.
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RESULTS AND DISCUSSION
The requisite common intermediate 6 for the preparation of title piperidine alkaloids 1-3 were synthesized from commercially available p-anisaldehyde, which was converted into anti-1,2-dibenzyl ether 4 by Brown's asymmetric aldol reaction and subsequent perbenzylation, as shown in Scheme 1. The regioselective and diastereoselective CSI reaction of 4 was carried out in anhydrous toluene at -78 ℃ for 24 h, followed by desulfonylation with an aqueous 25% sodium sulfite solution, to afford the anti-1,2-amino alcohol 5 with excellent diastereoselectivity (anti/syn = 49:1, 98% ds by NMR analysis) in 90% yield. Allylation of 5 followed by ring-closing metathesis afforded compound 6 in high yields.
In order to introduce the 4,5-trans-dihydroxyl group into the olefin moiety of 6, we first planned the epoxidation of olefin and regioselective ring-opening using an acetoxy reagent to afford the trans-diol 8, which could be easily converted to D-1-deoxynojirimycin (1 
Scheme 2
Since epoxidation route proved troublesome, we next focused on diastereoselective dihydroxylation of olefin 6 and subsequent regioselective stereochemical inversion of the resulting diol 10 to accomplish the total synthesis of D-1-deoxynojirimycin series 1-3, as described in Scheme 3. inversion of OH at C-4
1

Scheme 3
Initially, It was observed that the standard dihydroxylation of 6 using Upjohn's method 21 (cat. OsO 4 , NMO, 80% acetone) afforded a separable mixture of the diols 9 and 10 with a diastereoselectivity of 1:6.0 and in a combined yield of 75%. Similarly, the dihydroxylation in tert-butyl alcohol took favored 10 at the same level of diastereoselectivity (1:5.3) . However, Donohoe's condition 22 (1 equiv. of OsO 4 and 1 equiv. of TMEDA) did not afford the dihydroxylated compounds, probably because the internal alkene was less accessible to the bulky OsO 4 /TMEDA complex due to the presence of the pseudo-axial groups (OBn and p-MeOPh) . Because the stereochemical assignments of 9 and 10 proved to be difficult by 1 H NMR and nOe analysis, we attempted to determine the relative configurations of peracetylated compounds 11 and 12 using nOe experimental study, as shown in Figure 2 . From observations of vicinal coupling constants and nOe correlations, the dihydroxylation of 6 was concluded to have occurred preferentially due to the steric effect of the p-methoxyphenyl group to provide the diol 10 as a major isomer. Furthermore, structure of the peracetylated piperidines 11 and 12 allowed a remarkably undistorted chair-like conformation in the presence of axially-oriented bulky substituents, such as, p-methoxyphenyl and benzyloxy groups.
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For the syntheses of D-1-deoxymannojirimycin (2) and D-1-deoxyallonojirimycin (3), the diols 9 and 10, respectively, were converted into the peracetylated compounds 11 and 12 using acetic anhydride, 4-N,N'-(dimethylamino)pyridine and triethylamine in quantitative yields (Scheme 4). In this case, tosylation of 10 took place mainly at the C-4 equatorial OH, since the approach to the C-5 axial OH by TsCl was slightly shielded by the C-3 benzyloxy group due to 1,3-diaxial interaction. 
Scheme 5
As shown in Scheme 6, acetylation of the alcohol 15 produced the acetate 17 in 99% yield. To afford the required trans-diol, the stereo-inversion of the tosylate 17 was attempted using cesium acetate in the 
EXPERIMENTAL General
Commercially available reagents were used without additional purification, unless otherwise stated. All anhydrous solvents were distilled over CaH 2 or P 2 O 5 or Na/benzophenone prior to reaction. All reactions were performed under an inert atmosphere of nitrogen or argon. Nuclear magnetic resonance spectra ( To a stirred solution of 6 (3.5 g, 8. 11 mmol) in a mixture of acetone (40 mL) and H 2 O (8 mL) was added N-methylmorpholine N-oxide (5.0 mL, 24.33 mmol, 50% in H 2 O) and OsO 4 (1 crystal, ~5 mol %) under N 2 . The reaction mixture was stirred for 8 h at rt and quenched with a saturated aqueous Na 2 SO 3 (10 mL).
The aqueous layer was extracted with EtOAc (20 mL×2) and the organic layer was washed with H 2 O and brine, dried over MgSO 4 and concentrated in vacuo. The residue was purified by column chromatography (hexane/EtOAc 1:1) to afford a separable mixture (2.85 g, 75%, 9:10 = 1:6.0) of the diols 9 and 10 as colorless syrups. 9: syrup; R f = 0.27 (hexane/ 38, 55.42, 55.48, 64.92, 67.80, 70.59, 72.13, 78.14, 114.31, 127.34, 128.01, 128.20, 128.22, 128.69, 128.79, 129.83, 136.74, 137.83, 156.73, 158.80 11, 55.54, 55.55, 66.56, 68.00, 69.90, 73.06, 79.77, 114.73, 127.39, 127.64, 128.09, 128.35, 128.54, 128.78, 128.92, 136.73, 136.94, 157.53, 159.19 .34, 21.05, 39.10, 55.58, 55.59, 65.49, 67.91, 68.87, 72.11, 75.69, 114.22, 126.42, 127.96, 128.15, 128.21, 128.24, 128.70, 128.78, 130.01, 136.70, 137.47, 156.71, 158.47, 169.83, 170.28 20.98, 53.64, 59.86, 60.91, 67.67, 68.09, 68.76, 71.02, 127.89, 128.25, 128.40, 128.68, 128.75, 129.26, 130.09, 133.81, 136.18, 156.48, 165.23, 169.37, 169.80; HRMS (FAB) 
(2R,3R,4S,5S)-3-Benzoyloxy-1-benzyloxycarbonyl-4,5-diacetoxy-2-(hydroxymethyl)piperidine (14).
To a stirred solution of 12 (0. 20.92, 21.10, 43.57, 57.78, 61.43, 67.01, 67.41, 67.88, 68.16, 128.10, 128.35, 128.59, 128.73, 130.10, 130.14, 133.50, 136.50, 156.71, 165.92, 170.37, 170.63 
D-1-Deoxymannojirimycin (2).
A solution of 13 (40 mg, 0.082 mmol) in a mixture of 6 N HCl (1.7 mL) and MeOH (1. 3488, 2921, 2857, 2724, 2356, 1699, 1599, 1455, 1374, 1295, 1245, 1174, 1132, 1016 90, 46.56, 55.57, 56.41, 68.08, 68.48, 73.37, 75.72, 77.33, 114.84, 126.94, 127.25, 128.06, 128.34, 128.44, 128.51, 128.76, 128.85, 130.15, 133.94, 136.63, 136.67, 145.29, 157.32, 159.33; HRMS (FAB) 3343, 2922, 2855, 1698, 1604, 1509, 1452, 1356, 1249, 1176, 1119, 1028 86, 43.18, 54.54, 55.56, 65.67, 67.96, 71.94, 76.85, 76.92, 114.75, 127.53, 127.56, 127.68, 127.78, 127.98, 128.04, 128.16, 128.62, 128.68, 129.83, 134.18, 136.60, 137.95, 144.69, 156.93, 159.26; HRMS (FAB) 2923, 2853, 1739, 1702, 1609, 1512, 1454, 1423, 1364, 1245, 1176, 1129, 1017 21.90, 42.68, 55.57, 57.06, 67.78, 67.86, 72.35, 75.18, 75.28, 114.80, 127.43, 127.46, 127.64, 127.94, 128.07, 128.21, 128.44, 128.67, 130.16, 133.76, 136.60, 138.46, 145.34, 157.08, 159.32, 170.80 .90, 21.07, 42.04, 55.56, 58.30, 64.52, 67.64, 70.85, 71.90, 73.19, 114.23, 127.44, 127.88, 127.97, 128.13, 128.58, 128.61, 131.22, 136.69, 137.83, 156.42, 159.02, 169.82, 170 20.92, 21.04, 42.51, 54.47, 59.98, 65.92, 68.03 (two carbons), 72.26, 128.00, 128.39, 128.72, 128.74, 129.92, 133.44, 136.36, 156.14, 166.78, 170.32, 170.97 
